The NHS Gene Cataract X-Linked Genetic Test, available at DNA Labs UAE for a cost of 4400 AED, is a specialized diagnostic tool designed to identify mutations in the NHS gene, which are known to cause X-linked congenital cataracts. This type of cataract is inherited in an X-linked recessive pattern, predominantly affecting males, and is characterized by the clouding of the lens of the eye that is present from birth or develops shortly after. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities associated with this condition. Identifying these mutations can provide crucial information for families regarding the inheritance pattern, potential for recurrence in future generations, and options for genetic counseling. It is an invaluable resource for affected individuals and their families, offering insights into the genetic underpinnings of X-linked congenital cataracts and guiding decisions regarding management and treatment.
The GJA8 Gene Cataract-Microcornea Syndrome Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the GJA8 gene, which are linked to the development of Cataract-Microcornea Syndrome. This genetic condition is characterized by the presence of cataracts along with microcornea, a condition where the cornea's diameter is less than 10 mm in both eyes, potentially leading to visual impairment.
The test is conducted through a detailed analysis of the patient's DNA to identify any genetic alterations in the GJA8 gene, which plays a crucial role in the development and maintenance of eye lens transparency and corneal size. Identifying mutations in this gene can help in confirming the diagnosis, understanding the risk of transmitting it to offspring, and potentially guiding treatment and management decisions for affected individuals.
At DNA Labs UAE, the cost of the GJA8 Gene Cataract-Microcornea Syndrome Genetic Test is set at 4400 AED. The test provides a crucial resource for families and individuals at risk of this genetic syndrome, offering insights that can lead to early intervention and personalized care plans to manage the condition effectively.
The "IARS2 Gene Cataracts Growth Hormone Deficiency Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the IARS2 gene. Mutations in this gene are associated with a rare, inherited condition that can lead to the development of early-onset cataracts, growth hormone deficiency, and potentially other health issues. This test is crucial for individuals who exhibit symptoms related to these conditions or have a family history of similar genetic disorders. By analyzing the IARS2 gene, healthcare providers can confirm a diagnosis, allowing for early intervention and management of the condition. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high-quality, reliable results for patients and their families.
The ACO2 gene cerebellar-retinal degeneration infantile genetic test is a specialized diagnostic procedure designed to identify mutations in the ACO2 gene, which are linked to a rare, inherited neurodegenerative disorder. This condition is characterized by early-onset degeneration of the cerebellum and retina, leading to symptoms such as poor muscle coordination, visual impairment, and intellectual disability. Early detection through this genetic test can facilitate timely intervention and management strategies to improve the quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the ACO2 gene test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to accurately identify mutations in this specific gene. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, paving the way for personalized treatment plans and preventive measures for associated conditions.
The PRPH2 Gene Choroidal Dystrophy Central Areolar Type 2 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the PRPH2 gene, which are linked to the development of Central Areolar Choroidal Dystrophy Type 2 (CACD2). This condition is a rare, inherited eye disorder that affects the central area of the retina, leading to progressive vision loss. The test is crucial for early detection and management of the disease, offering insights into potential treatment paths and helping in family planning decisions. Conducted at the state-of-the-art facilities of DNA Labs UAE, the test cost is set at 3200 AED. This genetic testing is a significant step towards personalized medicine, providing patients and their families with crucial information about their genetic health and predisposition to this specific form of choroidal dystrophy.
The "CTC1 Gene Coat Plus Syndrome Genetic Test" is a specialized genetic screening designed to identify mutations in the CTC1 gene, which is closely associated with Coat Plus Syndrome. This syndrome is a rare genetic disorder characterized by a variety of symptoms including retinal dystrophy, intracranial calcifications, bone marrow failure, and others. The test plays a crucial role in the early diagnosis and management of the condition, allowing healthcare professionals to tailor treatments and interventions to the specific needs of the patient.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, this test is priced at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic testing, ensuring accurate and reliable results. By opting for this test, patients and their families can gain invaluable insights into their genetic makeup, paving the way for informed healthcare decisions and personalized medical care.
The "WFS1 Gene Cataract Type 41 Genetic Test" is a specialized diagnostic procedure designed to detect mutations in the WFS1 gene, which are associated with Cataract Type 41, a specific form of cataract. This condition is characterized by the clouding of the eye's lens, leading to impaired vision. The test is crucial for individuals with a family history of this condition, as early detection can facilitate timely intervention and management strategies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test offers a comprehensive analysis of the WFS1 gene to identify any genetic anomalies that could predispose an individual to develop Cataract Type 41. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed using advanced genetic sequencing technologies.
The cost of the WFS1 Gene Cataract Type 41 Genetic Test at DNA Labs UAE is set at 4400 AED. While the price may seem steep, the value of the test lies in its ability to provide crucial information about an individual's genetic predisposition to cataracts, thereby allowing for early and more effective management of the condition.
The "UNC45B Gene Cataract Type 43 Genetic Test" is a specialized diagnostic tool designed to detect mutations in the UNC45B gene, which have been linked to the development of Cataract Type 43. This condition is a rare, inherited form of cataract that can lead to impaired vision or blindness if left undiagnosed and untreated. The test aims to identify individuals at risk of developing this type of cataract, enabling early intervention and management strategies to preserve vision.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab. The sample is then analyzed for specific genetic alterations in the UNC45B gene that are known to cause Cataract Type 43. This precise genetic testing method allows for accurate diagnosis, guiding healthcare providers in recommending appropriate treatments or preventive measures.
The cost of the "UNC45B Gene Cataract Type 43 Genetic Test" at DNA Labs UAE is set at 4400 AED. While the price may seem significant, the value of the test lies in its ability to provide crucial information about an individual's genetic predisposition to this rare form of cataract, potentially saving sight through timely medical interventions.
The OCA2 Gene Albinism Oculocutaneous Type 2 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the OCA2 gene, which are responsible for oculocutaneous albinism type 2 (OCA2). This condition is characterized by reduced pigmentation in the hair, skin, and eyes, and can also lead to vision problems and increased susceptibility to sun damage. The test is crucial for early diagnosis, enabling appropriate management and care strategies for individuals with this condition. Priced at 4400 AED, the test involves analyzing the patient's DNA sample to detect any genetic abnormalities associated with OCA2, providing essential information for families and healthcare providers in managing the condition effectively.
The TYRP1 gene albinism oculocutaneous type 3 genetic test is a specialized diagnostic tool used to identify mutations in the TYRP1 gene, which are responsible for oculocutaneous albinism type 3 (OCA3), a form of albinism characterized by reduced melanin pigment in the hair, skin, and eyes. This condition can lead to visual problems and increased susceptibility to sun damage due to the lack of melanin. The test involves analyzing the patient's DNA to detect any abnormalities or mutations in the TYRP1 gene, providing crucial information for diagnosis, management, and genetic counseling.
The test is available at DNA Labs UAE, a leading facility in genetic testing and personalized medicine. The cost of the TYRP1 gene albinism oculocutaneous type 3 genetic test is 4400 AED. This investment covers the comprehensive process of collecting the sample, conducting the genetic analysis, and providing a detailed report on the findings. The results from this test can help in tailoring the management plan for individuals with OCA3, including strategies to protect the skin and eyes from sun exposure and addressing vision problems.
